The proliferation and invasion of stomach cancer cells were decreased when the ADAM17 was knockdown from these cells, and the ability of proliferation and invasion was significantly enhanced after these cancer cells were transfected with ADAM17-shRNA [19]. Here, ADAM17 is linked to cancer.